Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

Abbott (NYSE: ABT) today announced new clinical data supporting its minimally invasive therapies for treating AFib.

Learn about surgical options for hypertrophic cardiomyopathy (HCM), including septal myectomy, septal ablation, and heart ...

The system enters a field that sees PFA catheters largely displacing thermal modalities for catheter ablation of AF.

Volt Pulsed Field Ablation System (PFA) is being trialed for the first time in the UK at Belfast Royal Victoria Hospital (RVH ...

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients ...

A landmark clinical trial from St Bartholomew’s Hospital reveals that the Apple Watch detects recurring AFib faster and reduces unplanned hospitalizations by half following catheter ablation.

At 1 year, nearly 80% of patients with atrial fibrillation treated with an FDA-approved spherical pulsed field ablation ...